Tag Archives: Type 1 diabetes vaccine – Teplizumab – BCG vaccine diabetes – GAD65 vaccine – Diabetes immunotherapy – T1D clinical trials – Diabetes prevention

The Diabetes Vaccine & Immunotherapy Clinical Trials Tracker is a comprehensive real-time dashboard monitoring breakthrough prevention and treatment strategies for Type 1 diabetes. This platform tracks over 20 active clinical trials, including the landmark FDA-approved teplizumab (Tzield®)—the first disease-modifying therapy that delays T1D onset by approximately 2 years in high-risk individuals. The tracker covers revolutionary… Read More »